Parnassus Investments LLC Has $96.48 Million Holdings in CME Group Inc. $CME

Parnassus Investments LLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 1.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 353,308 shares of the financial services provider’s stock after acquiring an additional 6,564 shares during the quarter. Parnassus Investments LLC owned 0.10% of CME Group worth $96,481,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of CME. Asset Dedication LLC boosted its position in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the period. FNY Investment Advisers LLC acquired a new stake in CME Group during the 4th quarter worth about $27,000. Hilton Head Capital Partners LLC acquired a new stake in CME Group during the 4th quarter worth about $28,000. Legacy Wealth Managment LLC ID boosted its position in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after acquiring an additional 71 shares during the period. Finally, Global Wealth Strategies & Associates boosted its position in CME Group by 1,250.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 100 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of CME Group stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel directly owned 7,192 shares in the company, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 44,044 shares of company stock valued at $13,297,507 in the last three months. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the subject of a number of research reports. Argus restated a “hold” rating on shares of CME Group in a research report on Wednesday, March 4th. Erste Group Bank lowered CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. Piper Sandler lifted their price target on CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a report on Wednesday, April 15th. Keefe, Bruyette & Woods initiated coverage on CME Group in a report on Wednesday, April 8th. They set a “market perform” rating and a $305.00 price target for the company. Finally, Barclays reduced their price target on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a report on Thursday, April 23rd. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $305.71.

Get Our Latest Stock Report on CME

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

CME Group Stock Down 0.6%

Shares of CME stock opened at $262.18 on Friday. The stock’s 50 day simple moving average is $285.34 and its 200 day simple moving average is $288.20. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a twelve month low of $244.56 and a twelve month high of $329.16. The company has a market capitalization of $95.00 billion, a price-to-earnings ratio of 22.37, a PEG ratio of 2.95 and a beta of 0.21.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping the consensus estimate of $3.11 by $0.25. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same period in the previous year, the business posted $2.80 EPS. As a group, research analysts predict that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be given a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.